Keyword Connections

hydroxychloroquine

Journals

28

1 current medicinal chemistry

2 The Science of the total environment

3 the journal of physical chemistry b

4 british journal of pharmacology

5 Diabetes research and clinical practice

6 Asian journal of psychiatry

7 the american journal of medicine

8 annals of the rheumatic diseases

9 heart rhythm

10 Journal of medical virology

11 medicina

12 lupus science & medicine

13 Journal of the American College of Cardiology

14 The FEBS Journal

15 Anais brasileiros de dermatologia

16 clinical pharmacology and therapeutics

17 the lancet public health

18 Travel medicine and infectious disease

19 the lancet infectious diseases

20 journal of thoracic oncology : official publication of the international association for the study of lung cancer

21 dermatologic therapy

22 international journal of antimicrobial agents

23 ACS medicinal chemistry letters

24 microbes and infection

25 autophagy

26 Current drug metabolism

27 nuklearmedizin nuclear medicine

28 annals of the american thoracic society

Research Groups

0

No Research Group Connected

Bibliographies

91

1 A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?

2 Nuclear medicine in SARS-CoV-2 pandemia: 18F-FDG-PET/CT to visualize COVID-19.

3 Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.

4 Online learning in the time of COVID-19.

5 LUNG CANCER SURGICAL MANAGEMENT DURING THE OUTBREAK OF COVID-19.

6 COVID-19 in the perioperative period of lung resection: a brief report from a single thoracic surgery department in Wuhan, China.

7 Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies.

8 Can post-exposure prophylaxis for COVID-19 be considered as one of outbreak response strategies in long-term care hospitals?

9 Chloroquine Paradox May Cause More Damage Than Help Fight COVID-19.

10 COVID-19 and diabetes management: What should be considered?

11 Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19.

12 A case of facial atrophic sarcoidosis in an adolescent, successfully treated by the combination of prednisone and hydroxychloroquine.

13 Virological and Clinical Cure in Covid-19 Patients Treated with Hydroxychloroquine: A Systematic Review and Meta-Analysis.

14 SARS CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus.

15 : hydroxychloroquine, covid-19 and the role of the rheumatologist.

16 Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.

17 Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated with Hydroxychloroquine and/or Azithromycin.

18 Applications of 3D Printing Technology to Address COVID-19 Related Supply Shortages.

19 Effect of changing case definitions for COVID-19 on the epidemic curve and transmission parameters in mainland China: a modelling study.

20 Connecting clusters of COVID-19: an epidemiological and serological investigation.

21 [Hydroxychloroquine. Cardiology's viewpoint in times of coronavirus pandemic].

22 A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2.

23 Interactions of recommended COVID-19 drugs with commonly used psychotropics.

24 Open questions for harnessing autophagy-modulating drugs in the SARS-CoV-2 war: Hope or Hype?

25 Structural basis of potential binding mechanism of remdesivir to SARS-CoV-2 RNA dependent RNA polymerase.

26 Review on the clinical pharmacology of hydroxychloroquine sulfate for the treatment of COVID-19.

27 Pulse Oximetry for Monitoring Patients with COVID-19 at Home: Potential Pitfalls and Practical Guidance.

28 Repositioning PARP inhibitors for SARS-CoV-2 infection (COVID-19); a new multi-pronged therapy for ARDS?

29 QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review.

30 Synthesis of Novel G Factor or Chloroquine-Artemisinin Hybrids and Conjugates with Potent Antiplasmodial Activity.

31 Chloroquine commonly induces hormetic dose responses.

32 clinical evaluation of selected pharmacological treatments used for coronavirus (covid-19) pandemic

33 porphyria cutanea tarda (pct) experience in victoria, australia: a case series and literature review

34 screening for chloroquine maculopathy in populations with uncertain reliability in outcomes of automatic visual field testing

35 hidroxicloroquina na hemossiderose pulmonar idiopática: caso clínico hydroxychloroquine in pediatric idiopathic pulmonary hemosiderosis: a case report

36 clinical significance of serum and urinary interleukin-6 in systemic lupus erythematosus patients

37 Hydroxychloroquine usage in US patients, their experiences of tolerability and adherence, and implications for treatment: survey results from 3127 patients with SLE conducted by the Lupus Foundation of America.

38 Liquid Silicone-Induced Extensive and Debilitating Granulomatosis Responding to Hydroxychloroquine.

39 Meeting the Potential Emergency Global Drug Supply Challenge of Hydroxychloroquine for COVID-19.

40 Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base.

41 Hydroxychloroquine and covid-19.

42 Does hydroxychloroquine prevent the transmission of covid-19?

43 SLE, hydroxychloroquine and no SLE patients with covid-19: a comment.

44 Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

45 Hydroxychloroquine Retinopathy in the Era of Advanced Imaging Modalities

46 Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries

47 Covid-19, dans les brouillards français de l’hydroxychloroquine

48 Generalized Pustular Figurate Erythema A Newly Delineated Severe Cutaneous Drug Reaction Linked with Hydroxychloroquine

49 Hydroxychloroquine Mitigates the Production of 8-Isoprostane and Improves Vascular Dysfunction: Implications for Treating Preeclampsia

50 Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial

51 Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence

52 Hydroxychloroquine-induced Retinal Toxicity

53 Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus

54 The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study

55 Additional Analyses to Confirm Relationship of Hydroxychloroquine Blood Levels to Retinopathy: Comment on the Article by Petri et al

56 Hydroxychloroquine suppresses lung tumorigenesis via inducing FoxO3a nuclear translocation through STAT3 inactivation

57 Evaluation of an Immediate-Release Formulation of Hydroxychloroquine Sulfate With an Interwoven Pediatric Taste-Masking System

58 Drug-induced Sweet's syndrome related to hydroxychloroquine: About 2 cases

59 Covid-19: six million doses of hydroxychloroquine donated to US despite lack of evidence

60 Hydroxychloroquine-induced auditory toxicity

61 Comment on: Adherence to hydroxychloroquine improves long-term survival of patients with systemic lupus erythematosus

62 Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology

63 An update on the use of hydroxychloroquine in cutaneous lupus erythematosus: A systematic review

64 Hydroxychloroquine-induced erythema multiforme

65 Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy

66 Hydroxychloroquine may reduce risk of Pneumocystis pneumonia in lupus patients: A Nationwide, population-based case-control study

67 Rapamycin and hydroxychloroquine combination alters macrophage polarization and sensitizes glioblastoma to immune checkpoint inhibitors

68 Hydroxychloroquine-induced bull's eye maculopathy

69 Hydroxychloroquine Induced Retinopathy: A Case Series

70 Effect of Hydroxychloroquine on the Retinal Layers: A Quantitative Evaluation with Spectral-Domain Optical Coherence Tomography

71 Response to the editorial “COVID-19 in patients with cardiovascular diseases”: Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes

72 Rheumotologitsts' view on the use of hydroxychloroquine to treat COVID-19

73 Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review.

74 Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection.

75 Synthesis of deuterium labelled chloroquine, hydroxychloroquine and their metabolites

76 Systematic review of registered trials of Hydroxychloroquine prophylaxis for COVID-19 health-care workers at the first third of 2020

77 Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study.

78 Dose Optimization of Hydroxychloroquine for COVID-19: Do Blood Concentrations Matter?

79 near-infrared reflectance bull’s eye maculopathy as an early indication of hydroxychloroquine toxicity

80 treatment of rheumatoid arthritis with methotrexate alone or a combination of methotrexate and hydroxychloroquine

81 extensive discoid lupus erythematosus in a hiv patient responding to hydroxychloroquine monotherapy

82 development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine

83 In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

84 Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial

85 Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy

86 Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

87 Hydroxychloroquine for Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: Challenges to Trial Conduct During the Global Pandemic

88 In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

89 Hydroxychloroquine prophylaxis for COVID-19 contacts in India

90 Compassionate Use of Hydroxychloroquine in Clinical Practice for Patients With Mild to Severe COVID-19 in a French University Hospital

91 A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19